PSORIATIC ARTHRITIS

This study looks at the long-term safety and effectiveness of tildrakizumab for people with psoriatic arthritis, a condition causing joint pain and swelling. About 529 adults who completed a prior study will continue receiving the drug. The main goals are to track side effects an…

This study looked at how well a metal plate (A.L.P.S. Proximal Humerus Plating System) works for fixing broken upper arm bones. It included 135 adults who needed surgery for a fresh fracture. The main goal was to see how many people needed another surgery within a year due to pro…

This study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA) who haven't responded to standard treatments. About 684 participants will receive one of the two drugs and be monitored for joint and skin improvement. The main go…

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for adults with active psoriatic arthritis. About 1,100 people who finished earlier studies will receive the drug and be monitored for side effects and how well it controls their condition. Th…

This study watches for side effects in 881 people with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or psoriasis who receive Remsima under the skin. It aims to see how safe the injection is over time. Participants must have active disease that didn't respond…

This study tests a daily pill called deucravacitinib against a placebo in 670 adults with active psoriatic arthritis who have never taken biologic drugs. The goal is to see if the drug reduces joint pain and swelling and improves skin symptoms. Participants will be monitored for …

This study aims to find a faster way to detect psoriatic arthritis (PsA) in people with psoriasis. Instead of relying on busy doctors to screen patients, researchers are sending screening questionnaires directly to 18,000 adults with psoriasis. The goal is to see if this direct-t…

This study tests whether a dedicated care coordinator can help people with psoriasis or psoriatic arthritis lower their risk of heart disease. About 520 adults aged 40-75 who are not already on cholesterol medication will receive support to manage risk factors like high cholester…

This study tests an online program designed to help people with inflammatory arthritis (like rheumatoid arthritis or lupus) keep their jobs. Participants get access to eLearning, an occupational therapist, and a vocational counselor. The goal is to see if the program improves wor…

This study looks at whether healthcare professionals in Saudi Arabia are aware of and follow safety measures for the drug Leflunomide (ARAVA), used for rheumatoid and psoriatic arthritis. Researchers will survey about 3,500 doctors and pharmacists to see if they received and read…

This study tests whether a smartphone app can help people with psoriatic arthritis manage their condition with fewer in-person visits. About 278 adults who already use certain arthritis medications will use the app to report symptoms. Researchers will check if the app reduces how…

This study was designed to track pregnancies in women with rare autoimmune diseases like lupus, arthritis, and scleroderma. The goal was to learn about complications and improve care. However, the study was withdrawn before enrolling any participants, so no results are available.

This study looks at whether giving people with inflammatory arthritis extra support—like a list of local resources, help from a community specialist, or a nurse navigator—can reduce missed doctor visits. About 100 adults with conditions like rheumatoid arthritis or lupus who have…

This study is a large registry that follows 5,000 people with psoriatic arthritis or spondyloarthritis to see how well approved treatments work in real life and what side effects occur. Researchers will also track how these diseases progress over time and what other health issues…